Osteoporosis

Latest News

Osteoporosis Prevalence at Femur Neck, Lumbar Spine 12.3%

The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6% among adults aged 50 years and older in 2017 to 2018.

Evidence, Primary Considerations for Bisphosphonate Drug Holidays in Patients With Osteoporosis

By

Rita Aghjayan

Authors of the review discuss primary considerations and areas for future research regarding bisphosphonate drug holiday duration in patients with osteoporosis.

Experts Address Osteoporosis Therapy and COVID-19 Vaccination

In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19 vaccination.

ASBMR, AACE, NOF Develop Joint Guidance on COVID-19 Vaccination and Osteoporosis Management

By

Inga Back, MPH

ASBMR, AACE, Endocrine Society, ECTS, IOF, and NOF developed guidance on COVID-19 vaccination and osteoporosis management.

Bone Turnover Lower Among Men With Type 2 Diabetes Mellitus, A1c Greater Than 7%

By

Endocrinology Advisor Contributing Writer

Study authors identified whether the hemoglobin A1c threshold level where reduction in bone turnover begins.

Sydney AFF Score Quickly and Accurately Detects Atypical Femur Fractures in Women

By

Rose Reeb

The Sydney AFF Score is a tool to help differentiate atypical from typical femur fractures in women, independent of bisphosphonate use.

Resistance Exercise After Bariatric Surgery Prevents Bone Loss

By

Lauren Biscaldi

Patients who have had bariatric surgery are at high risk of fractures due to bone loss, but now researchers say that resistance, high-impact and balance exercises can protect these patients from bone mineral density loss.

Men With Diffuse Idiopathic Skeletal Hyperostosis at Higher Risk for Vertebral Fractures

By

Jessica Nye, PhD

The objective of this study was to analyze the risk of incident vertebral and nonvertebral fracture in men with DISH.

Osteoporosis Treatments

Osteoporosis treatment and prevention doses including recommended calcium and vitamin D supplemental doses.

Risks After Denosumab Discontinuation Linked to Age and Prior Therapy

By

Lauren Biscaldi

Researchers sought to identify potential vertebral fracture and bone loss risk factors after discontinuation of denosumab therapy and initiation of other therapy.

Comparing Free and Bioavailable vs Total 25(OH)D to Predict Bone Health

By

Lauren Biscaldi

Researchers sought to investigate the impact of vitamin D-specific variables on indices of bone and mineral metabolism in older adults.